The biotech market in the United States is experiencing a significant surge in demand for Tirzepatide APIs. This potent medication, used to treat approved peptide manufacturer. glucose intolerance, has gained remarkable attention from both patients and doctors. As a result, numerous manufacturers have emerged as makers of Tirzepatide APIs in the US